IDSA

Effects of Semaglutide on Cognitive Function in People with HIV: A Randomized Controlled Trial

In CID, Ornina Atieh, MD, and colleagues investigate the effect of semaglutide on cognitive function in people with #HIV and the possible mediation of this effect by changes in adiposity or inflammation. https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaf577/8287292

JID for Clinicians: The vaginal microbiome and HPV-related cancer, outpatient flu antiviral treatment and more Learn about the gut microbiome and clinical infections, flu-associated hospitalization rates and other research ready to inform clinical practice.

On IDSA’s & HIVMA’s Science Speaks blog: Learn about JID's latest monthly roundup of papers relevant to clinicians, including insights into the vaginal microbiome and HPV-related cancer, impacts of outpatient antiviral treatment on flu hospitalizations and more. https://bit.ly/3WqJ34w

IDSA is pleased to announce Ronald G. Nahass, MD, MHCM, FIDSA, as the Society’s new president beginning Oct. 23.

Learn about Dr. Nahass and the new IDSA Board of Directors: https://bit.ly/47ls48R

We danced the night away at the #IDWeek2025 Culture Club: A Celebration of Diversity, hosted by the IDSA Foundation. 💃🕺

Congratulations to Ravi Jhaveri, MD, FIDSA, recipient of IDSA’s 2025 Society Citation Award! 🎉 Dr. Jhaveri has advanced leadership development in the ID community, including assisting in the launch of IDSA’s Leadership Institute.

Learn more: https://bit.ly/3JnAtAA

Courage is contagious. 💪 IDSA and HIVMA members educated #IDWeek2025 attendees on how they can stand up for science & public health in today’s challenging political climate.

Urge your congressional reps to support ID funding, strengthen research & uphold evidence-based policy: bit.ly/3L4pbBK

Congrats to our newest class of FIDSAs! This distinguished designation honors those who have demonstrated excellence to the profession.

At #IDWeek2025? Stop by the IDSA Membership Booth to pick up your pin.

Apply to become a FIDSA: https://www.idsociety.org/membership-community/fellow-of-idsa/

Congratulations to Helen “Keipp” Talbot, MD, MPH, FIDSA, recipient of IDSA’s 2025 Anthony Fauci Courage in Leadership Award! 🎉

Her pioneering research on respiratory viruses and influenza vaccines has shaped current guidelines and advanced patient care.

Learn more: https://bit.ly/4oudRNA

Tickets for tonight’s Culture Club: A Celebration of Diversity party are available! Join your friends & colleagues on the rooftop of Ventanas Atlanta for a night of music, fellowship & fun.

🎫: https://bit.ly/3W1TqM1

Med students/residents: Get your free ticket by visiting the Foundation lounge!

An inspiring evening at the Dr. George W. Counts Interest Group Dinner at #IDWeek2025.✨Members gathered to celebrate connection, community, and their shared commitment to advancing health equity in infectious diseases.

Vaccination against herpes zoster, or shingles, is linked to lower risks of heart disease, dementia and death in people age 50 and older, according to new research presented at #IDWeek2025. https://bit.ly/471biNp

Immunization against respiratory syncytial virus delivered to infants following birth is safe and provides high antibody levels, regardless of the mother’s RSV vaccination status, according to new research presented at #IDWeek2025. bit.ly/3J9fIbS

Congratulations to Christopher D. Busky, CAE, recipient of IDSA’s 2025 Society Citation Award. 🎉

As CEO of IDSA & the IDSA Foundation, Chris has led through pivotal challenges, from advancing IDA&E to guiding the Society during COVID-19. We thank him for his steadfast leadership.

Congratulations to Cynthia Sears, MD, FIDSA, recipient of IDSA’s 2025 Alexander Fleming Award for Lifetime Achievement! 🎉

Her groundbreaking research, leadership & mentorship have advanced understanding of the microbiota’s role in colorectal cancer: bit.ly/4ndv5xG

Curious about advocacy for ID and HIV but don’t know where to start? Visit the IDSA booth in the exhibit hall TODAY from 1 to 2pm to chat with IDSA and HIVMA advocacy leaders about how to get involved.

Relax. Recharge. Get inspired. Stop by the Foundation Lounge and explore artwork from our art auction while learning about the IDSA Foundation.

If you make a gift, you’ll receive a free desk calendar ($50 donation) or free set of notecards ($100 donation)!

Infectious Diseases Society of America Infectious Diseases Society of America

As #IDWeek2025 begins, thousands of ID experts are uniting to defend science and public health. Urge Congress to fully fund ID research, preparedness and care, and hold the Administration accountable.

Your voice matters. Take action: https://idsociety.quorum.us/campaign/144678/

Take a break from #IDWeek2025 sessions and stop by the Foundation Lounge. Relax, recharge, explore the IDSA Foundation and browse artwork by Ana Velez, MD, FACP, FIDSA.

Make a gift and receive a free desk calendar ($50 donation) or free set of notecards ($100 donation)!

Tickets for Tuesday evening’s Culture Club: A Celebration of Diversity party are available! Join your friends and colleagues on the rooftop of Ventanas Atlanta for an evening of music, fellowship & fun. All tickets support the IDSA Foundation.

Learn more and purchase tickets: https://bit.ly/3W1TqM1

Rise and advocate! 💪 Join us this Tues. 10/21 at 7:45am for an empowering session on standing up for science and public health in today’s challenging political climate. Hear from member advocates who are making their voices heard and learn how you can too. #IDWeek2025

Mentorship matters! At the iDMentorship365 luncheon, mentors and mentees connected, shared ideas, and built relationships that will shape the future of infectious diseases. #IDWeek2025

IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients Anoma Nellore 1 1 1 2 2 2 2 1 2 Please refer to the following links for additional guidance on the use of COVID-19, Influenza, and RSV vaccines: Children & Adolescents: American Academy of Pediatrics American Academy of Family Physicians American Colle...

NEW #IDSAGuidelines! For the 2025-2026 respiratory season, IDSA strongly recommends age-appropriate COVID-19 vaccinations for immunocompromised adults and children: https://bit.ly/4nQWtmk

DOT-ting i's and crossing t's: More evidence for using long-acting glycopeptides to finish therapy of complicated S. aureus bacteremia A JAMA study looked at dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. Read IDSA's Journal Club review.

On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. https://bit.ly/4ncqnAt

Place your bid on original artwork that tells the story of infectious disease history. Artist and ID physician Ana Velez, MD, FIDSA, FACP, donated six new paintings to support ID research. Bidding ends Oct. 21.

Place your bid: https://givebutter.com/c/pclXSb/auction

New #IDSAGuidelines! IDSA has released updated evidence-based recommendations on the use of nirmatrelvir/ritonavir, remdesivir, and molnupiravir in adults with mild to moderate COVID-19: https://bit.ly/3W5IdtT

In children and adults with sore throat, IDSA Guidelines suggest using a clinical scoring system to determine who should be tested for Group A Streptococcal (GAS) Pharyngitis.

IDSA's Group A Streptococcal (GAS) Pharyngitis guidelines have been updated: https://bit.ly/4n8OWyj

Together on the path ahead: Advocating for our patients Andrew Trotter, MD, MPH, FIDSA, reflects on how to answer questions from patients and how to support and advocate for them in the midst of threats to funding for HIV.

On IDSA’s & HIVMA’s Science Speaks blog: In the midst of threats to funding for #HIV care and prevention, Andrew Trotter, MD, MPH, FIDSA, reflects on how to answer questions from patients and how to support and advocate for them. https://bit.ly/4ofPSBF

Carbapenem-resistant Organisms in Companion Animals in New York City, 2019–2022 Abstract. Carbapenem-resistant organisms (CRO) are a type of antibiotic-resistant bacteria that threaten human health. CRO can infect or colonize dogs and

Carbapenem-resistant organisms (CRO) are a type of antibiotic-resistant bacteria that threaten human health. In OFID, authors analyzed antimicrobial susceptibility data to characterize CRO prevalence among gram-negative cultured isolates from New York City dogs and cats. https://bit.ly/3KHLpth

We call for the reversal of these dangerous firings, and for Congress to move quickly to pass full-year spending bills that ensure that proposed cuts to public health are averted and federal appropriations are spent as Congress intended.

Our full joint statement: https://bit.ly/3WBh8ig

HIV and aging: Addressing new challenges and questions Evan Thornburg, MA, highlights key challenges and questions for the community to address in providing care for people who are aging with HIV.

On IDSA’s & HIVMA’s Science Speaks blog: Evan Thornburg, MA, highlights key challenges and questions for the HIV health care community to address in providing care for people who are aging with HIV. www.idsociety.org/science-spea...